A Dose Finding Study of Debio 4228 in Participants With Locally Advanced/Metastatic Prostate Cancer

Clinical Trials, Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06395753
Phase: PHASE2
Trial Summary: The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228. – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Debiopharm International SA
Acronym:

Pin It on Pinterest